Navigating the challenges of initiating pediatric device trials - a case study

Area of Science:

• Biomedical Engineering
• Clinical Trials
• Pediatric Medical Devices

Background:

• Pediatric medical devices face significant development hurdles compared to adult devices.
• Challenges include economic factors, smaller patient pools, anatomical variations, and regulatory complexities.
• Executing pediatric clinical trials is particularly difficult, impacting innovation in this sector.

Purpose of the Study:

• To investigate the requirements, challenges, timeline, and costs associated with multi-site pivotal clinical trials for pediatric medical devices.
• To analyze the factors influencing clinical trial execution for a Class II pediatric physiologic monitoring device.
• To identify best practices for expediting pediatric device trials while ensuring safety, ethics, and efficacy.

Main Methods:

• A case study approach focusing on a Class II pediatric physiologic monitoring device trial.
• Analysis of clinical trial agreement (CTA) and budget negotiation timelines.
• Evaluation of Institutional Review Board (IRB) processing times, including reliance models.
• Assessment of overall trial duration from site contact to first patient enrollment.

Main Results:

• The average time from site contact to first patient enrollment was 14 months.
• CTA and budget negotiations were the longest phases, averaging 10 and 9 months, respectively.
• IRB processing, including reliance, added an average of 6.5 months; regulatory oversight constituted nearly half of the costs.
• The COVID-19 pandemic significantly impacted enrollment timelines, though identified issues remain relevant post-pandemic.

Conclusions:

• Efficient and standardized processing of CTAs, budgets, and reliance IRB use are vital for expediting pediatric device clinical trials.
• Establishing a national clinical trials network could further streamline the pediatric device trial process.
• Addressing these logistical and administrative bottlenecks is essential for advancing pediatric medical device innovation.